Key Insights

Highlights

Success Rate

100% trial completion (above average)

Published Results

13 trials with published results (10%)

Research Maturity

80 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 128 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

21%

27 trials in Phase 3/4

Results Transparency

16%

13 of 80 completed with results

Key Signals

13 with results100% success

Data Visualizations

Phase Distribution

100Total
Not Applicable (69)
P 1 (1)
P 2 (3)
P 3 (7)
P 4 (20)

Trial Status

Completed80
Unknown18
Recruiting15
Active Not Recruiting6
Not Yet Recruiting5
Withdrawn4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 80 completed trials

Clinical Trials (128)

Showing 20 of 20 trials
NCT07856563Not Yet RecruitingPrimary

Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional Study

NCT03220555Not ApplicableCompleted

Efficacy of the Buzzy® Device on the Prevention of Health Care Induced Pediatric Pain in a Vaccination Center

NCT07798882Not ApplicableNot Yet Recruiting

Rule-Based High-Risk Flu

NCT07771738Not ApplicableCompletedPrimary

Microbe-Literacy Germ-Watching Workshops for Hygiene and Vaccine Acceptance in Sargodha, Pakistan

NCT06587243Not ApplicableActive Not RecruitingPrimary

"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake

NCT06387511Not ApplicableCompleted

Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months

NCT05078905Active Not Recruiting

Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

NCT07236034Not ApplicableRecruitingPrimary

ARISe at UMass Chan

NCT03587610Not ApplicableCompletedPrimary

Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older

NCT01054053Phase 4CompletedPrimary

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®

NCT07636525RecruitingPrimary

Sleep and Adolescent Vaccine Immunogenicity Pilot/Observational Study

NCT07007377Completed

Can the Ergometric Test in Flu-like Syndrome Help in the Outcome Analysis of Unvaccinated Patients

NCT07592260Not ApplicableRecruiting

OptiMAx Will Test Whether SQ-LNS Incentivises Vaccination Uptake in Rural Chad and Niger, With a Cost Effectiveness Analysis. It Will Also Look at Whether Having Received SQ-LNS Before Becoming Malnourished Leads to Better Outcomes for Children Treated Under the OptiMA Protocol.

NCT04936776Completed

Pediatric Vaccinations

NCT06844487Phase 3Active Not Recruiting

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

NCT07538349Not ApplicableCompletedPrimary

Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Intention: Online Experiment 3

NCT07532967Not ApplicableCompletedPrimary

Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Intention: Online Experiment 2

NCT07516600Not ApplicableCompletedPrimary

Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Intention: Online Experiment 1

NCT07096245Not ApplicableCompletedPrimary

Conectados: Social Networks and Social Media for Vaccine Uptake

NCT06890403Not ApplicableRecruitingPrimary

Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults

Scroll to load more

Research Network

Activity Timeline